The biotechnology company posted revenue of $125,000 in the period. In the final minutes of trading on Tuesday, the company's shares hit $2.29.
News
- Otonomy: 3Q Earnings Snapshot
- Harvard Bioscience: 3Q Earnings Snapshot
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Tuesday reported a loss of $2.6 million in its third quarter. The Holliston ...
- Xencor: 3Q Earnings Snapshot
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $21.8 million in the period, also exceeding ...
- Spindletop Pain Holdings and Tricity Pain Completes Acquisition of Advanced Consultants in Pain ...
Located in the Stone Oak area of San Antonio, TCPA and ACPC will continue ... services, healthcare IT, specialty pharmaceuticals, and biotechnology.
- Could Anixa Biosciences Inc (NASDAQ:ANIX) See a Reversal After More Sellers Came In?
The short interest to Anixa Biosciences Inc's float is 6.86%. ... their article: “Anixa Biosciences Announces Collaboration with Urology San Antonio on ...